Leyden Labs - Latest News and Information
Leyden Labs is a biotechnology company focused on developing mucosal immunity–based antiviral products, specifically nasal sprays containing antibodies designed to target respiratory viruses. Their approach aims to stop initial infection at the nasal gate and provide broad, lasting protection against known and emerging viruses. The company is based in Leiden, The Netherlands, with a global outlook that includes Asia and collaborations with academic and industry partners. Their portfolio emphasizes autonomous protection and clinical development of lead programs like PanFlu™ to mitigate endemic and pandemic threats.
No recent news for this company.
